Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK On A Knife Edge As EU Referendum Nears

Executive Summary

With the UK about to go to the polls in a once-and-for-all decision on EU membership, the stakes for the life sciences sector are high. The effects of a Brexit would be far-reaching, not only for the industry but also for other key groups such as regulators, patients and researchers.

Advertisement

Related Content

'We Cannot Afford To Be An Island': Bayer's UK CEO Shares Anti-Brexit Opinion
ABPI And Top Pharma Execs Come Out Against Brexit
EU Referendum: EFPIA, Witty And Soriot Show Their Hands

Topics

Advertisement
UsernamePublicRestriction

Register